Lab
Spectra Laboratories INC
Spectra Laboratories INC was paid $7.99M by Medicaid between Jan 2018 and Jul 2024, across 89 billing codes. Its largest line is 83970, — 26% of everything it billed.
33Billing provider infoSPECTRA LABORATORIES INC
MILPITAS, CA 95035
MILPITAS, CA 95035
33aNPI1003810375assigned 06/02/2005
33bProvider typeClinical Medical Laboratory
28Total paid$7.99M
24GClaims1,077,383
24DCodes billed89
24AFirst – last monthJan 2018 – Jul 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in California
Rank by total paid#83 of 561
Median peer was paid$222K
This provider vs. median36×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 345,344 | $2.42M | |
| 2019 | 253,472 | $1.90M | |
| 2020 | 245,489 | $1.83M | |
| 2021 | 227,330 | $1.74M | |
| 2022 | 4,240 | $70K | |
| 2023 | 732 | $10K | |
| 2024incomplete | 776 | $10K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 83970 | 26% | 63,659 | 56,885 | $2.12M | |
| 82728 | 8.1% | 57,736 | 51,497 | $650K | |
| 83540 | 6.2% | 88,921 | 82,324 | $496K | |
| 83550 | 6.1% | 65,011 | 61,245 | $486K | |
| 87340 | 5.5% | 51,548 | 47,868 | $439K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 5.2% | 17,501 | 16,408 | $417K |
| 84466 | 2.6% | 21,654 | 20,656 | $210K | |
| 82108 | 2.6% | 11,134 | 10,579 | $209K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2.6% | 6,675 | 3,236 | $209K |
| 85018 | 2.5% | 106,348 | 41,107 | $198K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 2.1% | 47,830 | 44,944 | $172K |
| 82947 | 2.1% | 51,662 | 45,016 | $166K |
77 more codes
| 84295 | 2.1% | 40,028 | $164K | |
| 86706 | 2.0% | 18,248 | $164K | |
| 80061 | Lipid panel | 1.7% | 22,685 | $135K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.6% | 21,033 | $125K |
| 84100 | 1.6% | 33,334 | $124K | |
| 84460 | 1.5% | 33,100 | $123K | |
| 84132 | 1.4% | 29,713 | $110K | |
| 82310 | 1.3% | 25,370 | $107K | |
| 86803 | 1.3% | 12,633 | $104K | |
| 83735 | 1.3% | 16,592 | $103K | |
| 86704 | <1% | 7,308 | $71K | |
| 82746 | <1% | 5,011 | $60K | |
| 85004 | <1% | 13,379 | $56K | |
| 85045 | <1% | 16,902 | $48K | |
| 80051 | <1% | 7,985 | $48K | |
| 84520 | <1% | 13,809 | $45K | |
| 82040 | <1% | 10,692 | $43K | |
| 82247 | <1% | 10,065 | $41K | |
| 85049 | <1% | 12,356 | $39K | |
| 85027 | <1% | 6,711 | $38K | |
| 85046 | <1% | 6,745 | $36K | |
| 84134 | <1% | 2,145 | $33K | |
| 85041 | <1% | 14,022 | $30K | |
| 82607 | <1% | 2,572 | $28K | |
| 85048 | <1% | 14,246 | $25K | |
| 80050 | General health panel | <1% | 1,043 | $24K |
| 84075 | <1% | 4,480 | $22K | |
| 80069 | <1% | 2,723 | $22K | |
| 82565 | <1% | 5,197 | $21K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 3,116 | $20K |
| 87040 | <1% | 2,145 | $18K | |
| 82570 | <1% | 4,895 | $18K | |
| 84155 | <1% | 5,097 | $17K | |
| 83615 | <1% | 11,366 | $16K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 2,269 | $16K |
| 84450 | <1% | 2,155 | $12K | |
| 82977 | <1% | 3,543 | $12K | |
| 82248 | <1% | 2,648 | $11K | |
| 82435 | <1% | 3,128 | $11K | |
| 80202 | <1% | 2,328 | $9K | |
| 84540 | <1% | 2,124 | $7K | |
| 85014 | <1% | 2,774 | $7K | |
| 82374 | <1% | 2,227 | $7K | |
| 80053 | Comprehensive metabolic panel | <1% | 579 | $6K |
| 87186 | <1% | 1,769 | $5K | |
| 84550 | <1% | 4,688 | $5K | |
| 82465 | <1% | 3,527 | $5K | |
| 87070 | <1% | 691 | $4K | |
| 83718 | <1% | 883 | $4K | |
| 86703 | <1% | 482 | $3K | |
| 84478 | <1% | 2,466 | $3K | |
| 87205 | <1% | 2,125 | $3K | |
| 85610 | <1% | 4,771 | $2K | |
| 87147 | <1% | 1,590 | $2K | |
| ATP03 | <1% | 830 | $2K | |
| 87075 | <1% | 146 | $1K | |
| ATP02 | <1% | 177 | $945.12 | |
| 82330 | <1% | 65 | $943.50 | |
| 83721 | <1% | 212 | $852.24 | |
| 87522 | Neg quan hep c or qual rna | <1% | 53 | $676.22 |
| 87077 | <1% | 99 | $623.14 | |
| 86140 | <1% | 278 | $484.86 | |
| 84439 | <1% | 234 | $455.57 | |
| 84630 | <1% | 207 | $416.81 | |
| ATP04 | <1% | 704 | $376.48 | |
| G0306 | Complete cbc, automated (hgb, hct, rbc, wbc, without platelet count) and automated wbc differential count | <1% | 50 | $313.54 |
| 89051 | <1% | 222 | $297.84 | |
| ATP08 | <1% | 27 | $235.71 | |
| 89050 | <1% | 147 | $228.94 | |
| ATP07 | <1% | 24 | $202.32 | |
| 86705 | <1% | 27 | $188.39 | |
| ATP05 | <1% | 17 | $96.72 | |
| 82945 | <1% | 543 | $73.02 | |
| 84153 | <1% | 39 | $39.36 | |
| 82272 | <1% | 60 | $35.49 | |
| 84165 | 0% | 13 | $0.00 | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialJOHNSON, CURTIS (GENERAL MANAGER VP OPERATIONS)
| Provider | Location | Paid |
|---|---|---|
| Stratford Hospital District | Stratford, TX | $146K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.